Literature DB >> 7774674

Effect of receptor density on the receptor-effector coupling: use of cloned and stably expressed alpha 1B-adrenoceptors in CHO cells.

K Horie1, G Tsujimoto.   

Abstract

Using Chinese hamster ovary cells stably expressing alpha 1B-adrenoceptor as a model, we investigated whether the changes in receptor density may influence the receptor-effector coupling relationship. Among the transfected cells, two clones which showed similar pharmacological properties but markedly differed in receptor density (Bmax were 1600 and 110,000 sites/cell, respectively), were examined. The phenoxybenzamine inactivation method showed that the alpha 1B-adrenoceptor occupancy and transients of cytosolic Ca2+ concentration ([Ca2+]i) response relationship was markedly nonlinear but similar in the two cell lines. The dose-response relationship for norepinephrine-induced [Ca2+]i response showed an increase in maximum effect with no change in agonist potency, and the increase in maximum effect was disproportionate to the difference in receptor density. The results indicate that the classical model of drug-receptor action cannot appropriately describe the coupling of alpha 1B-adrenoceptor to [Ca2+]i response in the single receptor expressing system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774674     DOI: 10.1016/0922-4106(95)90042-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Receptor-mediated stimulation of lipid signalling pathways in CHO cells elicits the rapid transient induction of the PDE1B isoform of Ca2+/calmodulin-stimulated cAMP phosphodiesterase.

Authors:  S Spence; G Rena; M Sullivan; S Erdogan; M D Houslay
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

2.  Characterization of alpha 1-adrenoceptors expressed in a novel vascular smooth muscle cell line cloned from p53 knockout mice, P53LMAC01 (AC01) cells.

Authors:  K Ohmi; H Shinoura; Y Nakayama; N Goda; G Tsujimoto
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.